Patent · US Active

Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched PCTA and synthesis method

US11426470B2 · kind B2 · utility

0Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2021
Grant dateAug 30, 2022
Priority date
Expiry dateAug 9, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F5/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a complex of formula (II) constituted of at least 80% of a diastereoisomeric excess comprising a mixture of isomers II-RRR and II-SSS of formulae:The present invention also relates to a process for preparing said complex of formula (II), and also to two synthetic intermediates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.